Product Information

BRIMONIDINE TARTRATE 0.1% DROP is a generic product labeled by Apotex Corp., priced at $7.4360 per ML under NDC 60505057701. Its NADAC has been published 153 times since Dec 20, 2023.

FDA first approved this application on Dec 21, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

BRIMONIDINE TARTRATE 0.1% DROP

brimonidine tartrate
$7.4360per ML

Strength

1 mg/mL

Manufacturer

Apotex Corp.

NDC

60505057701

Classification

Generic

Dosage Form

SOLUTION/ DROPS

Route

OPHTHALMIC

Effective Date

11/18/2026

Active Ingredients

BRIMONIDINE TARTRATE

Approval Type

Generic (ANDA)

FDA Application

ANDA078480

FDA Approved

12/21/2022

TE Code

AB

On Market Since

9/2/2023

Pharmacological Classes

Adrenergic alpha-Agonists
alpha-Adrenergic Agonist

Price Statistics

The NADAC for BRIMONIDINE TARTRATE 0.1% DROP has been published 153 times since Dec 20, 2023, and over the history we have for it it has declined 75.4%. The table below summarizes its recorded NADAC range and movement.

Current price$7.4360 per ML
All-time high$31.9324 (Feb 14, 2024)
All-time low$7.4360 (Nov 18, 2026)
52-week high$14.2000
52-week low$7.4360
Median price$15.3158
Average price$16.4147
Largest weekly change-35.2% (Apr 17, 2024)
Weeks tracked153
Tracking sinceDec 20, 2023

Price History

1W

-8.8%

1M

-17.9%

3M

-26.9%

6M

-28.4%

1Y

-48.3%

3Y

N/A

5Y

N/A

All

-75.4%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 24% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of BRIMONIDINE TARTRATE 0.1% DROP?

The current National Average Drug Acquisition Cost (NADAC) for BRIMONIDINE TARTRATE 0.1% DROP, manufactured by Apotex Corp., is $7.4360 per ML (NDC 60505057701), effective Nov 18, 2026.

How has the price of BRIMONIDINE TARTRATE 0.1% DROP changed over time?

Over the history we have for it, the NADAC for BRIMONIDINE TARTRATE 0.1% DROP has declined 75.4%. It has been tracked across 153 weekly CMS publications since Dec 20, 2023.

What are the highest and lowest recorded NADAC prices for BRIMONIDINE TARTRATE 0.1% DROP?

Since Dec 20, 2023, the NADAC for BRIMONIDINE TARTRATE 0.1% DROP has ranged from a low of $7.4360 (Nov 18, 2026) to a high of $31.9324 (Feb 14, 2024), with a median of $15.3158 per ML.

Are there cheaper alternatives to BRIMONIDINE TARTRATE 0.1% DROP?

Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BRIMONIDINE TARTRATE 0.1% DROP, is $5.6251 per ML — about 24% below BRIMONIDINE TARTRATE 0.1% DROP.

Who manufactures BRIMONIDINE TARTRATE 0.1% DROP?

BRIMONIDINE TARTRATE 0.1% DROP (NDC 60505057701) is labeled by Apotex Corp., and CMS classifies it as a generic product.